English Journal

Wu SQ, Xu ZZ, Niu WY, Huang HB, Zhan R.
International journal of molecular medicine.Int J Mol Med.2014 Aug;34(2):616-23. doi: 10.3892/ijmm.2014.1798. Epub 2014 Jun 6.
The introduction of bortezomib has resulted in a paradigm shift in the treatment of multiple myeloma (MM) and has contributed to the improved survival of patients with MM. Inevitably, resistance to therapy develops, and thus the clinical efficacy of bortezomib is hampered by drug resistance. The onc
PMID 24913180

Yamakawa N1, Okuyama K, Ogata J, Kanai A, Helwak A, Takamatsu M, Imadome K, Takakura K, Chanda B, Kurosaki N, Yamamoto H, Ando K, Matsui H, Inaba T, Kotani A.
Nucleic acids research.Nucleic Acids Res.2014 Apr;42(8):5289-301. doi: 10.1093/nar/gku137. Epub 2014 Mar 13.
Argonaute (Ago) proteins function in RNA silencing as components of the RNA-induced silencing complex (RISC). In lower organisms, the small interfering RNA and miRNA pathways diverge due in part to sorting mechanisms that direct distinct small RNA (sRNA) duplexes onto specific Ago-RISCs. However, su
PMID 24627180

Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis.

Riachy E1, Krauel L1, Rich BS1, McEvoy MP1, Honeyman JN1, Boulad F2, Wolden SL3, Herr HW4, La Quaglia MP5.
The Journal of urology.J Urol.2014 Jan;191(1):186-92. doi: 10.1016/j.juro.2013.08.007. Epub 2013 Aug 13.
PURPOSE: We retrospectively analyzed our institutional incidence of hemorrhagic cystitis, identified risk factors, and examined associations of risk factors with disease severity and genitourinary complication rates.MATERIALS AND METHODS: We reviewed charts of all consecutive pediatric patients trea
PMID 23954584